A tape head module assembly system is disclosed. The present disclosure provides therapeutic methods involving administering a subject compound, or a subject pharmaceutical composition. The pH-neutralized formulation of Botulinum toxin is pharmaceutically acceptable for administration to a patient and is significantly less painful than acidic formulations of Botulinum toxin or formulations of Botulinum toxin having unnecessary antigens. This diminishes the occurrence of cracks caused by stress concentration.